Hualan Biological Engineering
002007.SZ
#2887
Rank
C$6.41 B
Marketcap
$3.51
Share price
2.53%
Change (1 day)
-14.22%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): C$0.32 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are C$0.69 Billion. In 2023 the company made an earning of C$0.42 Billion, an increase over its 2022 earnings that were of C$0.30 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.32 B-22.32%
2023 C$0.42 B39.21%
2022 C$0.30 B-19.12%
2021 C$0.37 B-17.9%
2020 C$0.45 B37.11%
2019 C$0.33 B11.71%
2018 C$0.29 B50.84%
2017 C$0.19 B1.1%
2016 C$0.19 B23.49%
2015 C$0.15 B8.37%
2014 C$0.14 B10.83%
2013 C$0.13 B54.56%
2012 C$85.14 M-17.03%
2011 C$0.10 B-41.34%
2010 C$0.17 B6.15%
2009 C$0.16 B261.3%
2008 C$45.6 M85.75%
2007 C$24.55 M49.27%
2006 C$16.44 M56.98%
2005 C$10.47 M34.28%
2004 C$7.8 M